Skip to main content
Retour
LMAT logo

LeMaitre Vascular, Inc.

Qualité des données : 100%
LMAT
NASDAQ Healthcare Medical - Instruments & Supplies
107,86 €
▲ 1,55 € (1,46%)
Cap. Boursière : 2,46B
Fourchette du Jour
105,88 € 108,68 €
Fourchette 52 Semaines
71,42 € 115,33 €
Volume
236 539
Moyenne 50J / 200J
94,46 € / 88,84 €
Clôture Précédente
106,31 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (626 pairs)

Métrique Action Médiane du Secteur
P/E 42,6 0,4
P/B 6,2 2,9
ROE % 15,8 3,7
Net Margin % 23,1 3,8
Rev Growth 5Y % 12,8 10,0
D/E 0,5 0,2

Points Clés

Revenue grew 12,75% annually over 5 years — strong growth
Earnings grew 31,10% over the past year
ROE of 15,80% — decent returns on equity
Net margin of 23,13% shows strong profitability
Debt/Equity of 0,47 — conservative balance sheet
Generating 74,47M in free cash flow

Croissance

Revenue Growth (5Y)
12,75%
Revenue (1Y)13,53%
Earnings (1Y)31,10%
FCF Growth (3Y)58,92%

Qualité

Return on Equity
15,80%
ROIC8,80%
Net Margin23,13%
Op. Margin27,21%

Sécurité

Debt / Equity
0,47
Current Ratio12,89
Interest Coverage13,10

Valorisation

P/E Ratio
42,56
P/B Ratio6,24
EV/EBITDA38,49
Dividend Yield0,01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 13,53% Revenue Growth (3Y) 13,58%
Earnings Growth (1Y) 31,10% Earnings Growth (3Y) 38,48%
Revenue Growth (5Y) 12,75% Earnings Growth (5Y) 21,03%
Profitability
Revenue (TTM) 249,60M Net Income (TTM) 57,73M
ROE 15,80% ROA 9,38%
Gross Margin 71,53% Operating Margin 27,21%
Net Margin 23,13% Free Cash Flow (TTM) 74,47M
ROIC 8,80% FCF Growth (3Y) 58,92%
Safety
Debt / Equity 0,47 Current Ratio 12,89
Interest Coverage 13,10 Dividend Yield 0,01%
Valuation
P/E Ratio 42,56 P/B Ratio 6,24
P/S Ratio 9,84 PEG Ratio 1,06
EV/EBITDA 38,49 Dividend Yield 0,01%
Market Cap 2,46B Enterprise Value 2,61B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 249,60M 219,86M 193,48M 161,65M 154,42M
Net Income 57,73M 44,04M 30,11M 20,64M 26,91M
EPS (Diluted) 2,52 1,93 1,34 0,93 1,25
Gross Profit 178,54M 150,90M 127,05M 104,90M 101,38M
Operating Income 67,91M 52,26M 36,71M 26,83M 36,43M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 615,69M 551,82M 346,78M 310,48M 292,80M
Total Liabilities 222,17M 214,53M 48,88M 42,28M 38,65M
Shareholders' Equity 393,52M 337,29M 297,90M 268,20M 254,15M
Total Debt 185,59M 185,69M 19,10M 16,60M 15,94M
Cash & Equivalents 28,24M 25,61M 24,27M 19,13M 13,86M
Current Assets 468,23M 402,19M 194,60M 161,73M 139,88M
Current Liabilities 36,32M 30,61M 29,88M 25,33M 21,81M

Scores de Stratégies

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#879 of 1024
26
Custom Balanced Risk
#62 of 148
48

Activité Récente

Entré Cash Flow Compounder
Mar 24, 2026
Entré Balanced Risk
Mar 24, 2026